4-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-acetoxybenzoate

03/15/2012 - "Tumor xenografts in mice, were significantly reduced in volume and mass by HS-ASA treatment. "
03/15/2012 - "HS-ASA has anti-cancer potential against ER- breast cancer and merits further study."
10/01/2013 - "Hydrogen sulfide-releasing aspirin (HS-ASA) is a novel compound with potential against cancer. "
03/15/2012 - "Hydrogen sulfide-releasing aspirin (HS-ASA), a novel and safer derivative of aspirin, has shown promise as an anti-cancer agent. "
03/15/2012 - "Human colon, breast, pancreatic, prostate, lung, and leukemia cancer cell lines were treated with HS-aspirin, -sulindac, -iburofen, -naproxen, and their traditional counterparts. "

03/15/2012 - "HS-ASA has anti-cancer potential against ER- breast cancer and merits further study."

03/15/2012 - "We examined the growth inhibitory effect of HS-ASA via alterations in cell proliferation, cell cycle phase transitions, and apoptosis, using MDA-MB-231 cells as a model of triple negative breast cancer. "

03/15/2012 - "Therefore, HS-ASA induces phase-II enzymes, at least in part, through the action of H(2)S and by modulating Nrf2; these effects may be part of its mechanism of action against carcinogenesis."

03/15/2012 - "Human colon, breast, pancreatic, prostate, lung, and leukemia cancer cell lines were treated with HS-aspirin, -sulindac, -iburofen, -naproxen, and their traditional counterparts. "